Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frequency-demodulated US: evaluation in the liver. Work in progress.

D Aufrichtig, S Lottenberg, J Hoefs

    Radiology
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.

    Oncogene·2013
    Same author

    Periodontal innate immune mechanisms relevant to obesity.

    Molecular oral microbiology·2013
    Same author

    Recursive algorithms for implementing digital image filters.

    IEEE transactions on pattern analysis and machine intelligence·2012
    Same author

    Kinetics of ethanol degradation in forensic blood samples.

    Forensic science international·2006
    Same author

    Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

    Gut·2005
    Same author

    Live-donor liver transplantation: the USC experience.

    Acta chirurgica Belgica·2002

    This study examines a novel ultrasound technique called frequency-modulated imaging, which provides more detailed information than standard ultrasound. By analyzing 34 patients with liver disease, researchers found that this method better identifies signs of liver damage and correlates well with biopsy results.

    Area of Science:

    • Diagnostic imaging research within Frequency-demodulated US technology
    • Hepatology and clinical gastroenterology

    Background:

    No prior work had resolved the full diagnostic potential of frequency-modulated ultrasound for assessing diffuse hepatic conditions. Conventional imaging relies primarily on envelope data, which often lacks the sensitivity needed for early detection. This gap motivated the development of modalities that incorporate instantaneous frequency measurements. It was already known that standard ultrasound techniques frequently fail to capture subtle parenchymal changes. That uncertainty drove the investigation into whether frequency-modulated signals could offer superior diagnostic clarity. Prior research has shown that hepatic fibrosis alters tissue architecture in ways that standard methods may overlook. The current literature lacks comprehensive descriptions of how these advanced signals manifest in healthy versus diseased tissue. This study addresses these limitations by characterizing specific image features in clinical cohorts.

    Purpose Of The Study:

    The aim of this study is to evaluate the clinical utility of frequency-modulated ultrasound for assessing diffuse liver disease. Researchers sought to determine if this new modality provides superior diagnostic information compared to conventional envelope-based imaging. The investigation addresses the challenge of identifying subtle parenchymal abnormalities that standard ultrasound often fails to detect. By analyzing 34 patients with biopsy-proven conditions, the team examined the efficacy of instantaneous frequency signals. This work explores whether specific image features can accurately reflect the severity of hepatic fibrosis. The study intends to establish a visual grading system that correlates with established pathological standards. Motivation for this research stems from the need for more sensitive non-invasive diagnostic tools in hepatology. The authors aim to demonstrate that incorporating frequency data enhances the overall diagnostic capability of ultrasound examinations.

    Keywords:
    diagnostic ultrasoundhepatic fibrosismedical imaging technologyparenchymal disease

    Frequently Asked Questions

    The researchers propose that frequency-modulated imaging utilizes instantaneous frequency data alongside standard envelope information. This dual-signal approach allows for the detection of parenchymal abnormalities that conventional amplitude-based ultrasound often fails to demonstrate in patients with diffuse liver disease.

    The study utilized a visual grading system to assess eight distinct features identified within the frequency-modulated images. These specific image characteristics were evaluated in 34 patients to determine their relationship with the severity of hepatic fibrosis.

    The authors state that biopsy-proven data is necessary to validate the visual grading system. This clinical standard provides the ground truth required to confirm that the observed image features accurately reflect the actual levels of hepatic fibrosis.

    Related Experiment Videos

    Main Methods:

    Review Approach involved a clinical study of 34 patients diagnosed with biopsy-confirmed diffuse hepatic conditions. Investigators applied frequency-modulated ultrasound to capture instantaneous frequency data alongside standard envelope signals. The team established eight distinct visual features to characterize the resulting images in both healthy and diseased tissues. Researchers performed a comparative analysis between these new image features and traditional amplitude-based ultrasound results. The study design focused on visual grading to quantify the severity of parenchymal changes observed during the examinations. Clinical staff evaluated the diagnostic performance by correlating these grades with biopsy-derived fibrosis scores. This methodology allowed for a direct assessment of how well the new modality detects subtle tissue alterations. The approach ensured that all imaging findings were rigorously compared against established pathological standards.

    Main Results:

    Key Findings From the Literature indicate that frequency-modulated ultrasound demonstrates a strong correlation with biopsy-graded hepatic fibrosis levels. The study of 34 patients revealed that this modality consistently identifies signs of parenchymal abnormality. These specific indicators were frequently missed when using conventional amplitude-modulated imaging techniques. The researchers successfully characterized eight unique features within the frequency-modulated images of nondiseased livers. Visual grading of these features provided a reliable metric for assessing the extent of liver damage. The data show that patients with diffuse parenchymal disease exhibit clearer evidence of pathology under frequency-modulated imaging. This performance improvement highlights the utility of incorporating instantaneous frequency information into diagnostic ultrasound protocols. The results suggest that this approach offers enhanced sensitivity for detecting diffuse liver conditions compared to standard methods.

    Conclusions:

    Synthesis and Implications suggest that frequency-modulated ultrasound provides a more sensitive diagnostic tool than conventional amplitude-based imaging. The authors propose that the observed image features correlate significantly with the severity of hepatic fibrosis. These findings indicate that clinicians may achieve better visualization of diffuse parenchymal abnormalities using this advanced modality. The researchers highlight that the technique successfully identified disease evidence that standard methods often missed. This work demonstrates the potential for frequency-modulated signals to enhance the accuracy of non-invasive liver assessments. The authors conclude that the visual grading system aligns well with established biopsy-based grading standards. These results support the integration of instantaneous frequency data into routine diagnostic protocols for chronic liver conditions. Future clinical practice could benefit from the improved diagnostic sensitivity offered by this frequency-based approach.

    The researchers used frequency-modulated signals to provide a more detailed analysis of the liver parenchyma. In contrast, conventional amplitude-modulated imaging relies solely on envelope information, which the authors suggest is less effective at identifying early signs of diffuse parenchymal disease.

    The study measured the correlation between visual grading scores and biopsy-graded fibrosis levels. The authors report that this comparison shows a good correlation, suggesting the imaging features are reliable indicators of disease progression.

    The researchers propose that this modality offers a superior alternative to standard envelope imaging for identifying diffuse parenchymal abnormalities. They suggest that the technique provides clearer evidence of liver disease, which may improve diagnostic outcomes for patients.